Miracle Leaf® qualifying-conditions guide
Medical Marijuana for Alzheimer's Disease
Progressive neurodegenerative disease and the most common cause of dementia. Cannabis has limited evidence for managing behavioral and psychological symptoms of dementia (agitation, sleep disturbance, appetite loss); no evidence demonstrates disease-modifying effects.
What is Alzheimer's Disease?
Alzheimer's disease is a progressive neurodegenerative disorder and the most common cause of dementia, affecting an estimated 6.7 million Americans over age 65. Pathologically, the disease is characterized by amyloid plaques and tau-protein neurofibrillary tangles in the brain. Symptoms include memory loss, language difficulty, executive dysfunction, and (in later stages) behavioral and psychological symptoms of dementia (BPSD) such as agitation, aggression, sleep disturbance, and appetite loss.
Disease-modifying therapies (anti-amyloid antibodies) provide modest benefit at early stages. Most clinical care remains symptomatic.
Does cannabis help Alzheimer's Disease?
Evidence for cannabis or cannabinoids in Alzheimer's disease is limited and focused on symptomatic management of BPSD rather than disease modification. Small open-label studies have reported improvements in agitation, sleep, and appetite with oral cannabinoids (dronabinol, nabilone). No large randomized controlled trials have demonstrated cognitive benefit, disease-progression delay, or neuroprotective effects.
Alzheimer's disease, dementia, or "agitation of Alzheimer's" is a qualifying condition under several state medical cannabis programs. Caregivers should coordinate use with the patient's geriatric care team given the elevated risk of cognitive side effects and falls in this population.
Eligibility
State eligibility for Alzheimer's Disease
Whether this condition is listed varies by state program. A Miracle Leaf® physician determines eligibility during your evaluation.
| State | Qualifies? | Program |
|---|---|---|
| Florida | Not listed | Florida OMMU |
| Georgia | Yes | Georgia DPH Low-THC Registry |
| Texas | Yes | Texas Compassionate Use Program |
Telehealth visits are available in 22 states. See telehealth states
Common questions
Frequently asked questions
What does the evidence base say about cannabis for Alzheimer's disease?
Is any cannabis-derived product FDA-approved for Alzheimer's?
Are there practical concerns when older adults with dementia use cannabis?
Does cannabis slow or prevent Alzheimer's progression?
Sources and citations
Keep reading
Related guides
- All qualifying conditions
- Amyotrophic Lateral Sclerosis (ALS)
- Anxiety Disorders
- Autism Spectrum Disorder
- Cachexia (Wasting Syndrome)
- Cancer
- Chronic Pain
- Complex Regional Pain Syndrome
- Crohn's Disease
- Endometriosis
- Epilepsy
- Fibromyalgia
- Glaucoma
- Hepatitis C
- HIV/AIDS
- Huntington's Disease
- Inflammatory Bowel Disease
- Lupus (Systemic Lupus Erythematosus)
- Migraine
- Multiple Sclerosis Spasticity
- Muscular Dystrophy
- Chemotherapy-Induced Nausea and Vomiting
- Obsessive-Compulsive Disorder
- Opioid Use Disorder
- Parkinson's Disease
- Peripheral Neuropathy
- Post-Traumatic Stress Disorder (PTSD)
- Rheumatoid Arthritis
- Seizure Disorders
- Sickle Cell Disease
- Spinal Cord Injury
- Terminal Illness
- Tourette Syndrome
- Traumatic Brain Injury
- Ulcerative Colitis
- Georgia program
- Texas program
Ready to talk with a Miracle Leaf® physician?
Reviewed by Miracle Leaf® Editorial Team. This page summarizes current peer-reviewed evidence and federal guidance and is updated when the source documents materially change.